Clinical Trial Update: A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 study of GSK5733584 in combination with anti-cancer therapies for advanced gynecologic cancers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Drugs mentioned

• GSK5733584

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tumours, Gynecological | Phase 1, Phase 2 | Status: RECRUITING